Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV - Wikidata - awgldk - TriplyDB

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

http://www.wikidata.org/entity/Q24239828

about

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

http://www.wikidata.org/entity/Q24239828

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@ast

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en-gb

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@nl

type

label

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@ast

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en-gb

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@nl

prefLabel

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@ast

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en-gb

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@nl

P1433

Q24239828-3FA65532-7F44-4DC4-9BD8-0B63C3C56D98

P1476

Q24239828-D32F77C9-23BD-4AD9-9E41-50EA3F39EDD1

P2093

Q24239828-49588C85-FB8A-4709-9CD3-40BB528405F2

Q24239828-8BBD57B0-1E3C-47E4-AF1A-45E82174E37D

Q24239828-C1590F7D-10FC-4420-9F35-54B66E98EADE

Q24239828-E3AFD8CC-7221-4AA7-8300-F1355F068A58

P2860

Q24239828-00BEB8B8-8CB9-4948-B463-9D3C157B886F

Q24239828-50B84576-A420-4D68-AD49-CD8A1ED8F6F3

Q24239828-51CBFFE3-220F-42FA-9788-8BCE51DC5C8A

Q24239828-6CC0F452-B2C1-49E5-BA3F-DDB3EDE60B4A

Q24239828-9B97BFA4-5B36-49C9-8FF9-FCC253F92EFE

Q24239828-C066B670-0F00-4C58-8154-DF0EB22B1FC2

Q24239828-EAA4FE97-48AE-4AC8-9428-02D9E67F8694

Q24239828-EC6E76C8-B231-4994-8259-05498F94877F

Q24239828-F6D9761A-E581-4943-A7D8-2A8BC4AC556F

P31

Q24239828-BC901F4D-7F93-45B7-8F55-2769FD57542F

P356

Q24239828-F0F20244-778C-42E1-A763-7CF790BE7C09

P577

Q24239828-D4278859-4E12-4B01-81C8-12BD93270918

P356

14651858.CD008270

P1433

Cochrane Database of Systematic Reviews

P1476

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV

@en

P2093

Carlo Mengoli

http://www.w3.org/2001/XMLSchema#string

Giovanni Serpelloni

http://www.w3.org/2001/XMLSchema#string

Mario Cruciani

http://www.w3.org/2001/XMLSchema#string

Saverio G Parisi

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Measuring inconsistency in meta-analyses

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysis.

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA.

TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results.

Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients.

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

P31

scholarly article

P356

10.1002/14651858.CD008270

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime